Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0740030B2 - Drying reagent for agglutination reaction - Google Patents
[go: Go Back, main page]

JPH0740030B2 - Drying reagent for agglutination reaction - Google Patents

Drying reagent for agglutination reaction

Info

Publication number
JPH0740030B2
JPH0740030B2 JP62235012A JP23501287A JPH0740030B2 JP H0740030 B2 JPH0740030 B2 JP H0740030B2 JP 62235012 A JP62235012 A JP 62235012A JP 23501287 A JP23501287 A JP 23501287A JP H0740030 B2 JPH0740030 B2 JP H0740030B2
Authority
JP
Japan
Prior art keywords
particles
water
dye
agglutination reaction
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP62235012A
Other languages
Japanese (ja)
Other versions
JPS6478161A (en
Inventor
喬 前原
勝男 三谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokuyama Corp
Original Assignee
Tokuyama Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokuyama Corp filed Critical Tokuyama Corp
Priority to JP62235012A priority Critical patent/JPH0740030B2/en
Publication of JPS6478161A publication Critical patent/JPS6478161A/en
Publication of JPH0740030B2 publication Critical patent/JPH0740030B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、凝集反応用乾燥試薬に関するものである。更
に詳しくは、水不溶性無機粒子を用いることにより該試
薬の用事の粒子分散性が改善された凝集反応用乾燥試薬
を提供するものである。
TECHNICAL FIELD The present invention relates to a dry reagent for agglutination reaction. More specifically, the present invention provides a dry reagent for agglutination reaction in which particle dispersibility of the reagent is improved by using water-insoluble inorganic particles.

尚、本発明において、平均粒子径()とは粒子を透過
型電子顕微鏡で観察し、粒子の長手方向の直径を測定し
その平均の直径を算出したものを言う。又、本発明にお
いて、粒子分散性とは粒子が個々に分散している程度を
示す性質で、粒子容積が の範囲に含まれる粒子の全粒子に対する含有割合、即ち
粒子分散値(%)で表示したものを言う。該粒子分散値
は後述するように担体としての水不溶性無機粒子、及び
この無機粒子を用いて調製された凝集反応用乾燥試薬の
いずれにも使用される。
In the present invention, the average particle size () means that the particles are observed with a transmission electron microscope, the diameter in the longitudinal direction of the particles is measured, and the average diameter is calculated. Further, in the present invention, particle dispersibility is a property showing the degree of individual dispersion of particles, and the particle volume is The content ratio of the particles included in the range to all particles, that is, the particle dispersion value (%). The particle dispersion value is used for both water-insoluble inorganic particles as a carrier and a dry reagent for agglutination reaction prepared using the inorganic particles, as described later.

〔従来技術及び発明が解決しようとする問題点〕[Problems to be Solved by Prior Art and Invention]

近年、疾病の診断及び予後判定の為に、体液及び尿中に
分泌される生体成分を測定することが広く行なわれて来
ている。例えば、肝炎ウイルス、後天性免疫不全症候群
(エイズ)、成人T細胞白血病及び風疹等のウイルス感
染症、慢性関節リウマチ、全身性エリテマトーデス及び
橋本病等の自己免疫病、カンジダ、マイコプラズマ、溶
連菌及び梅毒等の細菌感染症、インスリン、ヒト絨毛性
ゴナドトロピン及びエストロジエン等のホルモン検査、
その他腫瘍マーカーの検査などがあげられる。
In recent years, it has been widely practiced to measure biological components secreted in body fluids and urine for diagnosis of diseases and prognosis. For example, hepatitis virus, acquired immunodeficiency syndrome (AIDS), viral infections such as adult T-cell leukemia and rubella, autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and Hashimoto's disease, candida, mycoplasma, streptococcus and syphilis etc. Tests for bacterial infections such as insulin, human chorionic gonadotropin and estrogen,
Other examples include examination of tumor markers.

これら疾病の診断は、検査対象の生体成分が微量である
為に従来の化学分析による検査では困難を極め、一般に
は抗原抗体反応を利用した免疫血清学的検査が利用され
て来た。この検査法の最大の特徴は、極めて高い感度と
特異性をもって体液中及び尿中に分泌される生体成分を
測定できる点にある。
Diagnosis of these diseases has been extremely difficult with conventional chemical analysis because of the small amount of biological components to be tested, and immunoserologic tests using antigen-antibody reaction have generally been used. The most important feature of this test method is that biological components secreted in body fluids and urine can be measured with extremely high sensitivity and specificity.

この免疫血清学的検査の一つに凝集反応法がある。この
凝集反応法とは、動物の赤血球、ポリスチレンラテック
ス、クレー等より成る粒子を担体に用い、これらに抗原
又は抗体を固定化(以下感作という)させたものと、検
体(生体成分を含む体液や尿のことをいう)とを混合
し、抗原抗体複合体形成で生じる担体の凝集反応物の大
きさ又は凝集反応像の強さの程度を測定することによっ
て、対象となる生体成分を測定する方法である。
One of the immunoserologic tests is the agglutination reaction method. The agglutination method is a method in which particles made of animal red blood cells, polystyrene latex, clay, etc. are used as a carrier, and an antigen or antibody is immobilized on these carriers (hereinafter referred to as sensitization), and a specimen (body fluid containing biological components). , Or urine) and measure the size of the agglutination product of the carrier or the intensity of the agglutination reaction image generated in the formation of the antigen-antibody complex, thereby measuring the target biological component. Is the way.

この凝集反応方法は、放射性免疫測定法(以下RIAと略
す)及び酵素免疫測定法(以下EIAと略す)等の免疫血
清学的検査上の標識法と異なり、特別で高価な設備が要
らず、操作が簡単で、しかも迅速な診断が可能という優
れた特徴があり有用性が高い。しかも最近、抗原及び抗
体の精製法の改善、感作法の改良及び判定法の工夫等に
より、凝集反応法の感度は著しく向上し、RIA及びEIAの
感度と匹敵する様になった。
This agglutination reaction method does not require special and expensive equipment unlike labeling methods in immunoserologic tests such as radioimmunoassay (hereinafter abbreviated as RIA) and enzyme immunoassay (hereinafter abbreviated as EIA). It is highly useful because of its excellent features that it is easy to operate and allows quick diagnosis. Moreover, recently, the sensitivity of the agglutination method has been remarkably improved by the improvement of the purification method of the antigen and the antibody, the improvement of the sensitization method, and the improvement of the determination method, and it has become comparable to the sensitivity of RIA and EIA.

ところで、担体に抗原又は抗体を感作させた凝集反応用
試薬は、分散液の状態では抗原又は抗体が著しく失活す
る傾向にあり、短期間のうちに試薬性能が低下する欠点
がある。これを解放する目的で一般に、凝集反応用試薬
を、例えば加熱又は常温下に乾燥し、長期間保存後に再
度、精製水、生理食塩水又は種々の緩衝液等に分散させ
て使用する方法が考えられたが、乾燥処理を施すことに
よって、担体に感作された生体物質の活性が低下した
り、また再分散後短時間で失活する傾向が生ずるなどの
問題があった。そこで、乾燥手段が種々検討され、凍結
乾燥が提案され、更に長期間性能が低下しない工夫も施
されるようになった。そして検査時に、この凍結乾燥し
た凝集反応用試薬に精製水、生理食塩水又は種々の緩衝
液を加え、完全に粒子が分散した状態の凝集反応用試薬
にして測定を行なう。この方法においても用事の試薬分
散性の良悪が試薬性能を左右する。すなわち用事の分散
性が悪く完全に粒子が分散されていない状態で検査を行
なえば、大きな凝集塊の存在が凝集反応像の外観を著し
く損うばかりでなく誤まった判定を下す原因ともなる。
更に、分散性が悪い試薬の場合は均一な分散までに時間
を要する為、迅速な診断という凝集反応法の特長を著し
く損なう欠点がある。
By the way, the reagent for agglutination reaction in which the carrier is sensitized with the antigen or the antibody has a drawback that the antigen or the antibody tends to be significantly inactivated in the state of the dispersion liquid, and the reagent performance deteriorates in a short period of time. Generally, for the purpose of releasing this, a method of using the reagent for agglutination reaction, for example, by heating or drying at room temperature and re-dispersing it in purified water, physiological saline or various buffer solutions after long-term storage is considered. However, there is a problem in that the activity of the biological substance sensitized to the carrier is lowered by the drying treatment, and there is a tendency that it is inactivated in a short time after redispersion. Therefore, various drying means have been studied, freeze-drying has been proposed, and further measures have been taken so that the performance does not deteriorate for a long period of time. Then, at the time of inspection, purified water, physiological saline, or various buffers are added to the freeze-dried agglutination reaction reagent to make an agglutination reaction reagent in which particles are completely dispersed, and measurement is performed. Even in this method, the performance of the reagent depends on the quality of the dispersibility of the reagent. That is, if the inspection is performed in a state in which the dispersibility of the work is poor and the particles are not completely dispersed, the presence of large aggregates not only significantly impairs the appearance of the aggregation reaction image, but also causes an erroneous determination.
Furthermore, in the case of a reagent having poor dispersibility, it takes time to uniformly disperse the reagent, which has a drawback that the feature of the agglutination reaction method of rapid diagnosis is significantly impaired.

従来の担体である赤血球やポリスチレンラテックスは上
記の用事の分散性が乏しいので次の様な凍結乾燥法の工
夫が試みられている。
Since red blood cells and polystyrene latex, which are conventional carriers, have poor dispersibility in the above-mentioned use, attempts have been made to devise the following freeze-drying method.

例えば、赤血球について云えば、特開昭48−26913、特
開昭54−23119には、赤血球の前処理を工夫することに
よる改良、特開昭50−13523、特開昭58−131566には凍
結乾燥時の浮遊液組成を工夫することによる改良、そし
て特開昭59−169504には凍結方法の改善によって試薬の
分散性を高める方法が記載されている。また、ポリスチ
レンラテックスを担体として使用する場合にも、凍結乾
燥時の浮遊液組成を多成分とする事による改良が報告さ
れている(特開昭59−109862)。
For example, as for red blood cells, JP-A-48-26913 and JP-A-54-23119 show improvements by devising pretreatment of red blood cells, and JP-A-50-13523 and JP-A-58-131566 show freezing. An improvement by devising the composition of the suspension during drying is described, and JP-A-59-169504 describes a method for improving the dispersibility of the reagent by improving the freezing method. Also, when polystyrene latex is used as a carrier, improvement by making the composition of the suspension liquid during freeze-drying multi-component has been reported (JP-A-59-109862).

上記の様に、従来の担体である赤血球及びポリスチレン
ラテックスでは、得られる試薬の性能を良好に維持する
為に非常に煩雑で精密な凍結乾燥法が要求されている。
従ってその凍結乾燥条件の調整を誤れば、試薬性能が極
めて悪くなる。
As described above, the conventional carriers, erythrocyte and polystyrene latex, require a very complicated and precise freeze-drying method in order to maintain the performance of the obtained reagent in good condition.
Therefore, if the lyophilization conditions are adjusted incorrectly, the reagent performance will be extremely poor.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者らは、かかる技術的背景のもとに鋭意研究を重
ねた結果、水に対する特定の接触角をもつ水不溶性無機
粒子を凝集反応性粒子に用いることにより、用事の試薬
の分散性に優れた凝集反応用乾燥試薬が得られることを
見出し、本発明を完成するに至った。
The inventors of the present invention have conducted extensive studies based on such technical background, and as a result, by using water-insoluble inorganic particles having a specific contact angle to water as aggregating reactive particles, the dispersibility of the reagent for errands can be improved. They have found that an excellent dry reagent for agglutination reaction can be obtained, and have completed the present invention.

本発明は、水に対する接触角80度以下である水不溶性無
機化合物であって、平均粒子径が0.1〜10.0μmで、粒
子分散値が80%以上の粒子の表面に生体物質を感作した
凝集反応性粒子の浮遊液を凍結乾燥して得た凝縮反応用
乾燥試薬である。
The present invention is a water-insoluble inorganic compound having a contact angle with water of 80 degrees or less, an average particle size of 0.1 to 10.0 μm, and a particle dispersion value of 80% or more of a particle sensitized with a biological substance on the surface of the aggregate. A dried reagent for condensation reaction obtained by freeze-drying a suspension of reactive particles.

上記凝集反応性粒子は、水に対する接触角が80度以下で
ある水不溶性無機粒子の表面に生体物質を感作した後、
適当な緩衝液に浮遊させる。ここで水とは、化学便覧
(基礎編I、日本化学会編、丸善)に記載されている化
学式H2O,分子量18.02の無味無臭、無色透明の液体であ
る。
The aggregating reactive particles have a contact angle with water of 80 degrees or less after sensitizing a biological substance to the surface of the water-insoluble inorganic particles,
Resuspend in an appropriate buffer. Here, water is a colorless and transparent liquid having a chemical formula H 2 O and a molecular weight of 18.02, which is tasteless, odorless, and colorless, which is described in the Chemical Handbook (Basic Edition I, edited by The Chemical Society of Japan, Maruzen).

本発明の水不溶性無機粒子とは、特に生理食塩水又は緩
衝液に対して不溶性を示すことが好ましい。例えば、本
発明の水不溶性粒子を生理食塩水中に一定濃度分散さ
せ、24時間放置後の生理食塩水中に溶出した無機化合物
の濃度が1000ppm以下、特に100ppm以下が好ましい。
The water-insoluble inorganic particles of the present invention preferably exhibit insolubility particularly in physiological saline or a buffer solution. For example, the water-insoluble particles of the present invention are dispersed in physiological saline at a constant concentration, and the concentration of the inorganic compound eluted in physiological saline after standing for 24 hours is preferably 1000 ppm or less, particularly preferably 100 ppm or less.

本発明の接触角とは、固体面上においた液の液滴の表面
と固体面との交点において、液滴に引いた接線と固体面
とがなす角で液を含む方の角をいう。この接触角は、一
般にぬれ性を表わすときに用いられる。ぬれ性は、例え
ば固体表面に液体をおいた前後のエネルギー差(Δγ)
として把えることができるので下記のyoungの式で表記
される。ここで液体の表面張力γlと接触角は実験的に
求め Δγ=γs−γsl=γlcosθ ……(1) γs:固体の表面張力 γl:液体の表面張力 γsl:界面張力 θ:接触角 ることができるのでぬれ性は上記(1)式により定量化
できる。接触角が0度に近づけば、完全に固体と液体は
ぬれた状態になり、180度に近づく程ぬれなくなる。
The contact angle of the present invention refers to the angle formed by the tangent line drawn to the droplet and the solid surface at the intersection of the surface of the liquid droplet placed on the solid surface and the solid surface and containing the liquid. This contact angle is generally used when expressing wettability. The wettability is, for example, the energy difference (Δγ) before and after the liquid is placed on the solid surface.
Since it can be grasped as, it is expressed by the young expression below. Here, the liquid surface tension γl and the contact angle are obtained experimentally Δγ = γs-γsl = γl cosθ (1) γs: solid surface tension γl: liquid surface tension γsl: interfacial tension θ: contact angle Therefore, the wettability can be quantified by the above formula (1). When the contact angle is close to 0 degree, the solid and the liquid are completely wet, and when the contact angle is close to 180 degree, they are not wet.

本発明の接触角は、通常使用されている接触角測定装置
(例えばゴニオメーター、エルマ社製)で測定されう
る。
The contact angle of the present invention can be measured by a commonly used contact angle measuring device (for example, goniometer, manufactured by Elma Co.).

本発明の水不溶性無機粒子は、水に対する接触角が80度
以下であれば特に限定されず用いうる。具体的に例示す
れば、シリカ、アルミナ、チタニア、ジルコニア、酸化
第二鉄、四三酸化鉄、酸化コバルト、酸化ニッケル等の
周期律表第III族、第IV族または第VIII族の金属又は半
金属の酸化物;水酸化アルニミウム、水酸化第二鉄、水
酸化クロム等の水酸化物;臭化銀塩化銀等のハロゲン化
物;硫化カドミウム等の硫化物;炭酸カルシウム、炭酸
マグネシウム等の炭酸塩;硫酸バリウム、硫酸ストロン
チウム等の硫酸等が挙げられる。また上記水不溶性無機
粒子としては複合酸化物も好適に使用され、例えば英国
特許第2115799号公報に示されるシリカと周期律表第I
族、第II族、第III族及び第IV族からなる群より選ばれ
た少なくとも1種の金属酸化物が挙げられ、該シリカが
80モル%以上含まれるものが好ましい。
The water-insoluble inorganic particles of the present invention may be used without particular limitation as long as the contact angle with water is 80 degrees or less. Specific examples include silica, alumina, titania, zirconia, ferric oxide, ferric tetroxide, cobalt oxide, nickel oxide, etc., Group III, Group IV or Group VIII metal or semi-group. Metal oxides; hydroxides such as aluminum hydroxide, ferric hydroxide and chromium hydroxide; halides such as silver bromide and silver chloride; sulfides such as cadmium sulfide; carbonates such as calcium carbonate and magnesium carbonate. And sulfuric acid such as barium sulfate and strontium sulfate. As the water-insoluble inorganic particles, complex oxides are also preferably used. For example, silica shown in British Patent No. 2115799 and I of the periodic table are used.
At least one metal oxide selected from the group consisting of Group III, Group II, Group III, and Group IV, and the silica is
Those containing 80 mol% or more are preferable.

更にまた、本発明の水不溶性無機粒子は接触角が80度以
下の条件を満足すれば、その外部もしくは内部に有機化
合物を含有してもよい。例えば、該水不溶性無機粒子の
生理食塩水または緩衝液に対する難溶性をより一層高
め、かつ感作の効率を向上させるため該粒子を表面処理
することもしばしば好適な手段である。この表面処理方
法は特に限定的でなく、シランカップリング剤あるいは
チタンカップリング剤などを用いた乾式法及び湿式法に
よる公知の表面処理方法が採用される。あるいはまた、
染料を用いて水不溶性無機粒子を着色することもしばし
ば好適な手段である。この着色化は、最終的に着色され
た凝集反応用乾燥試薬を用いた凝集反応のエンドポイン
トを肉眼で精度良く診断する必要のある場合には最適で
ある。この染料としては特に限定されず公知の染料から
必要に応じて選択して用いればよい。一般的にはカチオ
ン染料が最も効果的であり、次いで含金属染料、更に次
いで反応染料及び螢光増白染料が好適である。また用途
によっては上記各種染料より多少劣るケースもあるが分
散染料、直接染料、酸性染料、酸性媒染染料その他の染
料も十分に使用できる。
Furthermore, the water-insoluble inorganic particles of the present invention may contain an organic compound externally or internally as long as the contact angle satisfies the condition of 80 degrees or less. For example, surface treatment of the water-insoluble inorganic particles is often a preferable means in order to further increase the poor solubility of the water-insoluble inorganic particles in physiological saline or a buffer solution and to improve the efficiency of sensitization. The surface treatment method is not particularly limited, and a known surface treatment method by a dry method or a wet method using a silane coupling agent or a titanium coupling agent is adopted. Alternatively,
Coloring the water-insoluble inorganic particles with a dye is also often a suitable means. This coloring is optimal when the end point of the agglutination reaction using the finally colored dry reagent for agglutination reaction needs to be accurately diagnosed with the naked eye. The dye is not particularly limited and may be selected from known dyes as necessary and used. Generally, cationic dyes are most effective, followed by metal-containing dyes, then reactive dyes and fluorescent brightening dyes. Further, depending on the application, there are cases in which the dyes are slightly inferior to the above-mentioned various dyes, but disperse dyes, direct dyes, acid dyes, acid mordant dyes and other dyes can be sufficiently used.

本発明に使用される水不溶性無機粒子の平均粒子径
()は、特に限定的ではないが0.05〜200μm、好ま
しくは0.1〜10.0μmの範囲から選択される。平均粒子
径が0.1μmより小さいときは凝集反応用乾燥試薬の担
体として該粒子を使用する場合、沈降速度が小さいため
判定時間に長時間を必要とする傾向にある。また逆に平
均粒子径が10.0μmより大きくなると凝集像が不鮮明と
なり易く、鋭敏性が低下する傾向がある。
The average particle diameter () of the water-insoluble inorganic particles used in the present invention is not particularly limited, but is selected from the range of 0.05 to 200 μm, preferably 0.1 to 10.0 μm. When the average particle size is smaller than 0.1 μm, when the particles are used as a carrier for a dry reagent for agglutination reaction, the determination time tends to be long because the sedimentation speed is low. On the other hand, when the average particle diameter is larger than 10.0 μm, the agglomerated image tends to become unclear and the sensitivity tends to be lowered.

本発明で使用する水不溶性無機粒子の形状は特に限定さ
れず、多面体、柱形体、円錐体、球状体等の形で存在す
る粒子が採用される。特に球状体、就中真球状体のもの
は分散性がすぐれているので好適である。
The shape of the water-insoluble inorganic particles used in the present invention is not particularly limited, and particles existing in the shape of a polyhedron, a column, a cone, a sphere or the like are adopted. In particular, spherical particles, especially spherical particles are preferable because they have excellent dispersibility.

本発明で使用される水不溶性無機粒子の粒子分散値は80
%以上であることが好ましい。90%以上であれば更に好
ましい。粒子分散値が80%より小さくなると、該水不溶
性無機粒子を用いて製造された凝集反応用乾燥試薬を後
述する凝集反応に利用したとき凝集像と非凝集像の判定
が難かしくなる傾向にある。又、該水不溶性無機粒子の
粒度分布、即ち、各粒子の粒子径の標準偏差を平均粒径
で除して100をかけた値である粒子径の分布値(%)は3
0%以下、更には20%以下であることが好ましい。この
粒度分布は生体物質を感作させる場合高い固定化率を得
るため小さいほど良い。
The particle dispersion value of the water-insoluble inorganic particles used in the present invention is 80.
% Or more is preferable. 90% or more is more preferable. When the particle dispersion value is less than 80%, it tends to be difficult to determine the agglomeration image and the non-aggregation image when the dry reagent for the agglutination reaction produced using the water-insoluble inorganic particles is used in the agglutination reaction described below. . The particle size distribution of the water-insoluble inorganic particles, that is, the standard deviation of the particle size of each particle divided by the average particle size and multiplied by 100, the distribution value (%) of the particle size is 3
It is preferably 0% or less, and more preferably 20% or less. This particle size distribution is preferably as small as possible in order to obtain a high immobilization rate when sensitizing biological substances.

上記本発明で使用される水不溶性無機粒子の諸要件を勘
案すれば該粒子として接触角が80度以下でしかも平均粒
子径が0.1〜10.0μm且つ粒子分散値が80%以上で、核
部と該核部の表面にある着色層との2層構造よりなる粒
子であり、該核部は無機化合物で形成され且つ着色層は
染料又は染料と無機化合物との混合物で形成されてなる
水不溶性無機複合粒子が好適に採用される。或いは、平
均粒子径が0.1〜10.0μm且つ粒子分散値が80%以上
で、核部、該核部の表面にある着色層及び該着色層を被
覆した固定被覆層の少なくとも3層構造よりなる粒子で
あり、該核部は無機化合物で形成され、該着色層は染料
又は染料と無機化合物との混合物で形成され、該固定被
覆層は着色層より染料の含有量が少ない染料と無機化合
物との混合物又は染料を含まない無機化合物で形成され
てなる水不溶性無機複合粒子も好ましい。このような特
定の構造を有する水不溶性無機複合粒子は従来知られて
いない複合粒子であるが、その製造方法は特に限定され
ず、代表的なものを例示すれば次の通りである。
Considering the requirements of the water-insoluble inorganic particles used in the present invention, the particles have a contact angle of 80 degrees or less, an average particle size of 0.1 to 10.0 μm and a particle dispersion value of 80% or more, and a core part. A particle having a two-layer structure of a colored layer on the surface of the core, the core being formed of an inorganic compound and the coloring layer being formed of a dye or a mixture of a dye and an inorganic compound. Composite particles are preferably adopted. Alternatively, particles having an average particle diameter of 0.1 to 10.0 μm and a particle dispersion value of 80% or more and having at least a three-layer structure of a core portion, a colored layer on the surface of the core portion, and a fixed coating layer coating the colored layer. The core is formed of an inorganic compound, the colored layer is formed of a dye or a mixture of a dye and an inorganic compound, the fixed coating layer of a dye and an inorganic compound having a dye content less than the coloring layer. Water-insoluble inorganic composite particles formed of a mixture or an inorganic compound containing no dye are also preferable. Water-insoluble inorganic composite particles having such a specific structure are composite particles that have not been known so far, but the manufacturing method thereof is not particularly limited, and representative ones are as follows.

染料及び加水分解に供し、加水分解されて無機化合物と
なる原料被加水分解化合物(以下単に被加水分解化合物
ともいう)の少なくとも一部は溶解するが反応生成物は
溶解しない、中性又はアルカリ性の含水溶媒中に、該溶
媒に溶解しない核部となる微粒子の無機化合物を存在さ
せ、該溶媒に被加水分解化合物と染料を滴下し加水分解
を行うことにより製造する。
At least a part of the raw material to be hydrolyzed to be dyed and hydrolyzed to be an inorganic compound to be hydrolyzed (hereinafter also simply referred to as a hydrolyzable compound) is dissolved, but a reaction product is not dissolved. It is produced by allowing a finely divided inorganic compound, which is a core portion, that does not dissolve in the solvent to exist in a water-containing solvent, and adding a compound to be hydrolyzed and a dye to the solvent to perform hydrolysis.

上記複合粒子の製法にあっては、原料となる染料及び被
加水分解化合物は溶解するが加水分解物は溶解しない溶
媒が使用される。該溶媒は染料或いは被加水分解化合物
の種類に応じて上記性状のものを予め決定して使用すれ
ばよい。但しこれらの原料は完全に溶解する必要はな
く、その一部を溶解するものであれば使用出来る。通常
好適に採用される溶媒について具体的に示せば、例え
ば、後述する反応性、操作性、入手が容易なこと等の理
由で、一般にはメタノール,エタノール,イソプロパノ
ール,ブタノール,イソアミルアルコール,エチレング
リコール,プロピレングリコール等のアルコール溶媒が
好適に用いられる。またジオキサン,ジエチルエーテル
等のエーテル溶媒,酢酸エチルなどのエステル溶媒等の
有機溶媒を上記アルコール溶媒に一部混合して用いるこ
ともできる。
In the method for producing the composite particles, a solvent in which the dye and the compound to be hydrolyzed which are the raw materials are dissolved but the hydrolyzate is not used is used. As the solvent, those having the above-mentioned properties may be previously determined and used according to the kind of the dye or the compound to be hydrolyzed. However, these raw materials do not have to be completely dissolved, and any material that can dissolve a part thereof can be used. Specific examples of the normally employed solvent include, for example, methanol, ethanol, isopropanol, butanol, isoamyl alcohol, ethylene glycol, and the like because of the reactivity, operability, and ease of availability described later. An alcohol solvent such as propylene glycol is preferably used. Further, an organic solvent such as an ether solvent such as dioxane or diethyl ether or an ester solvent such as ethyl acetate may be partially mixed with the alcohol solvent.

前記溶媒中には後述する如く被加水分解化合物が加水分
解される必要があるので水が含有されている必要があ
る。該水の含有量は被加水分解化合物の種類又は溶媒の
アルカリ性度等によっても異なり一概に限定することが
出来ないが、一般には0.05〜5重量%の範囲から選べば
好適である。前記具体的に例示した溶媒にあっては例え
ばアルコールの如く、一般に上記範囲の水は含まれるも
のがあり、このような溶媒にあっては特に含水量を制御
する必要がない。
Since the compound to be hydrolyzed needs to be hydrolyzed as described below, the solvent must contain water. The content of the water varies depending on the kind of the compound to be hydrolyzed or the alkalinity of the solvent and cannot be unconditionally limited, but it is generally preferable to select it in the range of 0.05 to 5% by weight. Some of the solvents specifically exemplified above generally include water in the above range, such as alcohol, and it is not necessary to control the water content in such solvents.

また上記溶媒は、通常中性又はアルカリ性の状態で使用
するのが一般的である。溶媒が酸性である場合は加水分
解によって得られる特定複合体粒子の粒子分散性が著し
く小さく、ほとんどのケースに於いてゲル状の粉状物と
なり目的とする粒子を得ることが出来ないので好ましく
ない。また該溶媒をアルカリ性とする手段は如何なる方
法でもよいが一般にはアンモニア水または水酸化ナトリ
ウム,水酸化カリウム,水酸化リチウム等の水酸化アル
カリを添加するか、或いはこれらの化合物を併用する方
法が好適である。これらの化合物の添加量も特に限定せ
ず適宜決定して用いればよいが、一般にはアンモニア水
を用いるときはアンモニア濃度が5〜30重量%、好まし
くは10〜25重量%の範囲となるように選べば好適であ
る。またアンモニア水と水酸化アルカリとを併用すると
きは水酸化アルカリの添加量によって得られる粒子の大
きさを制御出来るのでしばしば好適な態様として使用さ
れる。例えば上記アンモニア水に水酸化アルカリ濃度が
0.05〜0.15重量%の範囲で使用され、該水酸化アルカリ
濃度が増加するに従って得られる粒子径が大きくなる傾
向を示す。
In addition, the above-mentioned solvent is generally used in a neutral or alkaline state. When the solvent is acidic, the particle dispersibility of the specific composite particles obtained by hydrolysis is remarkably small, and in most cases it becomes a gel-like powdery substance and the desired particles cannot be obtained, which is not preferable. . Any means may be used for making the solvent alkaline, but in general, ammonia water or alkali hydroxide such as sodium hydroxide, potassium hydroxide or lithium hydroxide is added, or a method of using these compounds in combination is preferable. Is. The addition amount of these compounds is not particularly limited and may be appropriately determined and used. Generally, when ammonia water is used, the ammonia concentration is adjusted to 5 to 30% by weight, preferably 10 to 25% by weight. It is suitable to choose. Further, when ammonia water and alkali hydroxide are used in combination, the size of the particles obtained can be controlled by the amount of alkali hydroxide added, so this is often used as a preferred embodiment. For example, the concentration of alkali hydroxide in ammonia water is
It is used in the range of 0.05 to 0.15% by weight, and the particle size obtained tends to increase as the alkali hydroxide concentration increases.

特定複合粒子の製法にあっては、前記含水溶媒中に、該
溶媒に溶解しない核部となる無機化合物を存在させてお
き、該溶媒に被加水分解化合物と染料を滴下し加水分解
反応を行うのが好ましい。
In the method for producing the specific composite particles, in the water-containing solvent, an inorganic compound serving as a core that does not dissolve in the solvent is allowed to exist, and a compound to be hydrolyzed and a dye are added dropwise to the solvent to carry out a hydrolysis reaction. Is preferred.

該核部となる無機化合物は前記したものが使用出来る
が、一般には後述する被加水分解化合物を溶媒中で予め
加水分解し、該溶媒に溶解しない化合物を析出させ、該
析出物を上記核部とする方法も好適に採用される。該溶
媒中に存在する核部の濃度は特に限定されず、必要に応
じて予め決定して使用すればよいが一般には0.1〜10重
量%の範囲から選ぶのが好適である。
As the inorganic compound to be the core, the above-mentioned ones can be used, but generally, the compound to be hydrolyzed to be described later is previously hydrolyzed in a solvent to precipitate a compound that is not soluble in the solvent, and the precipitate is used as the core part. The method of is also preferably adopted. The concentration of the core portion present in the solvent is not particularly limited and may be determined and used as necessary, but it is generally preferable to select from the range of 0.1 to 10% by weight.

染料及び被加水分解化合物は上記核部が存在する溶媒に
滴下される。従って該染料は予め溶媒に溶解させて用い
るか被加水分解化合物で溶液状のものに溶解させて用い
るのがよい。また被加水分解化合物も同様に溶液状にし
て使用するのが好ましい。勿論染料と被加水分解化合物
を同一の溶媒に溶解して、前記含水溶媒に同時に滴下す
ることも、別々の滴下装置から該含水溶媒に別々に滴下
することも必要に応じて選択できる。
The dye and the compound to be hydrolyzed are added dropwise to the solvent containing the core. Therefore, the dye is preferably dissolved in a solvent in advance or used as a solution to be hydrolyzed in a solution. It is also preferable to similarly use the compound to be hydrolyzed in the form of a solution. Of course, the dye and the compound to be hydrolyzed may be dissolved in the same solvent and added dropwise to the water-containing solvent at the same time, or may be added separately to the water-containing solvent from different dropping devices as required.

また前記原料を溶解した溶液の濃度は一般に低い法が好
ましいが、低くすぎると溶媒の使用量が著しく増大する
し、濃度が高すぎると反応の制御が難しくなったり取扱
いが不便になるので、これらを勘案して適宜決定すれば
よい。一般には原料濃度が50重量%以下、好ましくは5
〜50重量%の範囲の濃度として使用するのが最も好まし
い。
In addition, a method in which the concentration of the solution in which the raw materials are dissolved is generally low is preferable, but if the concentration is too low, the amount of the solvent used remarkably increases, and if the concentration is too high, it becomes difficult to control the reaction or the handling becomes inconvenient. It may be appropriately determined in consideration of the above. Generally, the raw material concentration is 50% by weight or less, preferably 5
Most preferably it is used as a concentration in the range of up to 50% by weight.

更にまた上記染料及び被加水分解化合物の滴下速度は得
られる複合粒子の粒子径及び粒子分散性に影響を与える
ので、他の条件に応じて予め決定して使用するのが好ま
しい。一般には含水溶媒の量の0.5〜10重量%好ましく
は0.5〜2重量%の量を1時間かけて滴下させることを
目やすにすればよい。例えば含水溶媒を2使用すれ
ば、原料は10〜200ml/時間の速度を目やすとすればよ
い。
Furthermore, since the dropping rate of the dye and the compound to be hydrolyzed affects the particle size and particle dispersibility of the obtained composite particles, it is preferable to determine and use it in advance according to other conditions. Generally, it may be convenient to add 0.5 to 10% by weight, preferably 0.5 to 2% by weight, of the amount of the water-containing solvent dropwise over 1 hour. For example, if two water-containing solvents are used, the raw material may be at a speed of 10 to 200 ml / hour.

前記原料として使用する被加水分解化合物はその一部例
えば10%以上が溶媒に溶解し、加水分解可能であるもの
であれば特に限定されず用いうる。一般に好適に使用さ
れる被加水分解化合物は金属のアルコキサイドである。
即ち一般式Mx(OR)x(但し、Mは金属又は半金属を示
し、xはMの原子価を示す)で示されるアルコサイド化
合物が好ましい。該一般式中、Rはアルキル基で、一般
にはメチル基,エチル基,イソプロピル基,ブチル基等
の低級アルキル基が好適に使用される。好適に使用され
るものを例示すれば次の通りである。即ち、一般には一
般式M3(OR13,M4(OR14,M8(OR13,(ただし、R1
はアルキル基)で表示される金属のアルコキサイドまた
は上記一般式中の一つまたは二つのアルコキシル基(OR
1)がカルボキシル基で置換された化合物が好ましい。
ここでM3は第III族の金属、M4は第IV族の金属、M8は第V
III族の金属で、具体的には、例えばアルミニウム,チ
タニウム,ケイ素,ジルコニウム,ゲルマニウム,ハフ
ニウム,錫,鉛,鉄,コバルト,ニッケル等が好適に使
用される。一般に好適に使用される上記化合物を具体的
に例示すると、Al(OC2H53,Al(OC3H73,Al(OC
4H9等のアルミニウムアルコキサイド及び上記Alに
代って、Bなどで代替した第III族金属のアルコキサイ
ド;Ti(O−isoC3H74,Ti(O−nC4H94,Ti(O−CH2
CH(C2H5)C4H94,Ti(O−C17H354,Ti(O−isoC3H
7〔OCH(CH3)CHCOCH32,Ti(O−nC4H9〔OC2
H4N(C2H4OH)2,Ti(OH)〔OCH(CH3)COOH〕2,T
i(OCH2CH(C2H5)CH(OH)C3H74,Ti(O−nC4H9
(OCOC17H35等のチタンアルコキサイド及び上記Ti
に代って、Si,Zr,Ge,Hf,Sn,Pb等で代替した第IV族金属
のアルコキサイド;Fe(OC2H53,Fe(O−nC3H73,Fe
(O−nC4H93,Fe(O−secC4H93,Fe(O−tertC
4H9等の鉄アルコキサイド及び上記Feに代って、Co,
Ni等で代替した第VIII族金属のアルコキサイド等であ
る。またCaCl2,Ca〔HCO6H4COO〕・2H2Oなどの化合物
も上記の金属のアルコキサイドに混合して使用できる。
The compound to be hydrolyzed to be used as the raw material is not particularly limited as long as a part of the compound to be hydrolyzed can dissolve in a solvent and can be hydrolyzed. The generally used hydrolyzable compound is a metal alkoxide.
That is, an alcoside compound represented by the general formula Mx (OR) x (wherein M represents a metal or a metalloid, and x represents a valence of M) is preferable. In the general formula, R is an alkyl group, and generally, a lower alkyl group such as a methyl group, an ethyl group, an isopropyl group, a butyl group or the like is preferably used. The following is an example of what is preferably used. That is, in general, the general formula M 3 (OR 1 ) 3 , M 4 (OR 1 ) 4 , M 8 (OR 1 ) 3 , (where R 1
Represents an alkoxide of a metal represented by an alkyl group or one or two alkoxyl groups (OR
A compound in which 1 ) is substituted with a carboxyl group is preferable.
Where M 3 is a Group III metal, M 4 is a Group IV metal, M 8 is a Group V metal
Group III metals, specifically, aluminum, titanium, silicon, zirconium, germanium, hafnium, tin, lead, iron, cobalt, nickel and the like are preferably used. Specific examples of the above-mentioned compounds that are preferably used generally include Al (OC 2 H 5 ) 3 , Al (OC 3 H 7 ) 3 , Al (OC
4 H 9 ) 3 etc. and aluminum alkoxides such as Al and alkoxides of Group III metals substituted by B instead of Al; Ti (O-isoC 3 H 7 ) 4 , Ti (O-nC 4 H 9 ) 4 , Ti (O-CH 2
CH (C 2 H 5) C 4 H 9) 4, Ti (O-C 17 H 35) 4, Ti (O-isoC 3 H
7) 2 [OCH (CH 3) CHCOCH 3] 2, Ti (O-nC 4 H 9) 2 [OC 2
H 4 N (C 2 H 4 OH) 2 ] 2, Ti (OH) 2 [OCH (CH 3) COOH] 2, T
i (OCH 2 CH (C 2 H 5) CH (OH) C 3 H 7) 4, Ti (O-nC 4 H 9) 2
(OCOC 17 H 35 ) 2 etc. Titanium alkoxide and the above Ti
On behalf of, Si, Zr, Ge, Hf , Sn, alkoxides of Group IV metals replaced by Pb or the like; Fe (OC 2 H 5) 3, Fe (O-nC 3 H 7) 3, Fe
(O-nC 4 H 9) 3, Fe (O-secC 4 H 9) 3, Fe (O-tertC
4 H 9 ) 3, etc., instead of iron alkoxide and Fe above, Co,
Examples include alkoxides of Group VIII metals replaced with Ni. The CaCl 2, Ca [HCO 6 H 4 COO] compounds such as 2 · 2H 2 O can be used as a mixture to the alkoxide of the metal.

被加水分解化合物は1種だけを使用する必要はなく、同
時に2種以上を使用することもしばしば好ましい態様と
なる場合がある。また例えば英国特許第2,115,799号公
報実施例に記載されている如くアルコキキシランの低縮
合物と他の金属のアルコキシドを予め混合し混合溶液を
調製し、この調製した混合溶液を原料として使用するこ
とも出来る。
It is not necessary to use only one type of compound to be hydrolyzed, and it may often be a preferable embodiment to use two or more types at the same time. Further, for example, as described in British Patent No. 2,115,799, Examples, a low condensate of alkoxysilane and an alkoxide of another metal are mixed in advance to prepare a mixed solution, and the prepared mixed solution is used as a raw material. You can also

特定複合粒子の他の原料となる染料は一部例えば溶媒10
0重量部に対して1重量部以上好ましくは5重量部以
上、更に好ましくは10重量部以上を溶解するものであれ
ば特に限定されず用いうる。一般的には前記した各種染
料が好適に使用出来る。また該染料は一般に0.001〜1
重量%の濃度で使用するのが好ましい。更には溶媒中に
常に0.05〜0.5重量%好ましくは0.05〜0.2重量%の染料
が存在するように選んでもよい。
Part of the dye that is the other raw material of the specific composite particles is, for example, the solvent 10.
It is not particularly limited as long as it dissolves 1 part by weight or more, preferably 5 parts by weight or more, more preferably 10 parts by weight or more, relative to 0 parts by weight. Generally, the above-mentioned various dyes can be preferably used. The dye is generally 0.001 to 1
Preference is given to using concentrations of weight%. Furthermore, it may be chosen such that there is always 0.05 to 0.5% by weight, preferably 0.05 to 0.2% by weight, of dye in the solvent.

前記原料は溶媒中で直ちに加水分解反応を起し粒子状で
不溶性の析出物となる。該加水分解の条件は特に限定さ
れず、如何なる条件をも選び得るが一般には撹拌又は非
撹拌下に5〜50℃好ましくは10〜30℃の範囲の温度で実
施すると好適である。
The above raw material immediately undergoes a hydrolysis reaction in a solvent to form a particulate insoluble precipitate. The conditions for the hydrolysis are not particularly limited, and any conditions can be selected, but it is generally preferable to carry out the reaction with or without stirring at a temperature in the range of 5 to 50 ° C, preferably 10 to 30 ° C.

前記方法で加水分解して得られる染料と無機化合物との
複合粒子は平均粒子径()が0.1〜10.0μmのもので
非凝集性のもので、その粒子分散値も80%以上ほとんど
のケースで90%以上となる。このように溶媒中に核部が
存在していれば一見成長反応を阻害すると考えられる染
料の存在下でも加水分解反応が該核部に着色層を生成さ
せる形で進行することは全く驚ろくべき現象である。し
かも該染料は着色層に強固に固定され、該染料に応じた
着色性の複合粒子となる。このようにして得られた複合
粒子は染料を含まない無機化合物よりなる核部に染料と
無機化合物との混合物で構成された着色層が存在する複
合粒子となる。
The composite particles of the dye and the inorganic compound obtained by hydrolysis by the above method have a mean particle size () of 0.1 to 10.0 μm and are non-aggregating, and the particle dispersion value is 80% or more in most cases. 90% or more. As described above, it is quite surprising that the hydrolysis reaction proceeds in the form of forming a colored layer in the core even in the presence of a dye which is considered to hinder the growth reaction if the core is present in the solvent. It is a phenomenon. Moreover, the dye is firmly fixed to the colored layer to form a composite particle having colorability according to the dye. The composite particles thus obtained are composite particles in which a colored layer composed of a mixture of a dye and an inorganic compound is present in the core of the inorganic compound containing no dye.

また別の製法を例示すると次のような方法も好適であ
る。特定複合粒子の核部となる金属酸化物粒子として粒
子分散値が良好な例えば80%以上の且つ多孔性粒子を選
び染料を溶解した溶液と該多孔性粒子を接触させること
により、該多孔性粒子に染料を含浸させた特定複合粒子
が得られる。上記特定複合粒子の製法にあっては多孔性
粒子の選択が重要な要件となる。勿論該多孔性粒子の製
法は限定されるものではない。しかし一般には次のよう
な方法で得られた多孔性粒子が特に好適である。例えば
周期律表第III族,第IV族又は第VIII族の金属とカリウ
ム,ナトリウム,リチウム等のアルカリ金属とよりなる
複合酸化物を前記金属アルコキサイドの加水分解法によ
って製造する。次いで得られた複合酸化物を硫酸,硝
酸,塩酸等の鉱酸溶液と接触させることによって含有ア
ルカリ金属成分を溶出させると、得られる粒子は多孔性
でしかも粒子分析値が80%以上のすぐれたものとなる。
このような粒子を使用することにより、前記染料を含浸
させた即ち核部の表面に染料が存在した特定複合粒子と
なる。該特定複合粒子は必要に応じて乾燥して使用に供
するか後処理に供すればよい。
Moreover, the following method is also suitable when another manufacturing method is illustrated. The metal oxide particles serving as the core of the specific composite particles have a good particle dispersion value, for example, 80% or more and a porous particle is selected by contacting the porous particle with a solution in which a dye is selected and the porous particle is contacted. Specific composite particles in which the dye is impregnated are obtained. In the method for producing the above-mentioned specific composite particles, selection of porous particles is an important requirement. Of course, the method for producing the porous particles is not limited. However, in general, porous particles obtained by the following method are particularly suitable. For example, a composite oxide consisting of a metal of Group III, IV or VIII of the Periodic Table and an alkali metal such as potassium, sodium or lithium is produced by the above-mentioned metal alkoxide hydrolysis method. Then, the obtained composite oxide was contacted with a mineral acid solution such as sulfuric acid, nitric acid or hydrochloric acid to elute the contained alkali metal component, and the obtained particles were porous and had an excellent particle analysis value of 80% or more. Will be things.
By using such particles, it becomes a specific composite particle in which the dye is impregnated, that is, the dye is present on the surface of the core. If necessary, the specific composite particles may be dried before use or subjected to post-treatment.

場合によっては前記染料又は染料と無機化合物との混合
物で構成された着色層から該染料が溶出することもあ
る。このような場合には該着色層に更に染料含有量が少
ない無機化合物又は染料を全く含まない無機化合物の固
定被覆層を被覆させた3層構造或いは該3層構造に更に
前記積層をくりかえし4種以上の構造とした特定複合粒
子とすることが出来る。該3層以上の多層構造とする手
段は特に限定されず如何なる手段を利用してもよい。一
般に好適に採用される方法を例示すれば、前記核部とな
る無機化合物が存在する含水溶媒中に染料及び被加水分
解化合物を滴下し、該原料を加水分解させ2層構造の粒
子を生成させた後、或いは染料を含浸した多孔性粒子を
製造した後同一の反応容器中に該被加水分解化合物のみ
を更に滴下し加水分解を行う方法或いは前記2層構造の
粒子又は染料含浸の多孔性粒子の製造系から未反応又は
未含浸の染料を分離し、次いで被加水分解化合物を更に
滴下し加水分解させて特定複合粒子を得る方法である。
前者即ち反応を同一系で行う場合は3層構造の複合粒子
が得られるが、3層目の固定被覆層は核部への着色層が
形成されるとき消化された残りの染料が溶媒中に溶解さ
れているにもかかわらず、滴下する被加水分解化合物溶
液中に染料が含まれていないときは著しく染料の含有量
が少ない組成のものとなる。この場合は通常核部に直接
形成される着色層に含まれる染料の約1/5程度又はそれ
以下、好ましくは1/10以下となる。かかる現象も一般的
反応からすると驚異的な現象であるがその作用は現在の
とこら明らかではない。従って前記の特定複合粒子の製
法は特別の反応形式をとる必要はなく唯一の反応器で3
層以上の層を積層することによって得ることも出来る。
そしてこのようにして得られた複合粒子にあっては3層
目に少量の染料が含まれていても染料が溶出することは
ほとんどないすぐれた球状の粒子となる。
In some cases, the dye may be eluted from the colored layer composed of the dye or a mixture of the dye and an inorganic compound. In such a case, the colored layer is further coated with a fixed coating layer of an inorganic compound having a smaller dye content or an inorganic compound containing no dye, or a three-layer structure, or the above-mentioned lamination is repeated four times. The specific composite particle having the above structure can be obtained. The means for forming the multilayer structure of three or more layers is not particularly limited, and any means may be used. To give a typical example of methods that are preferably adopted, a dye and a compound to be hydrolyzed are dropped into a water-containing solvent in which the inorganic compound serving as the core is present, and the raw material is hydrolyzed to form particles having a two-layer structure. Or after producing dye-impregnated porous particles, a method of further dropping only the compound to be hydrolyzed into the same reaction vessel for hydrolysis, or the above-mentioned two-layer structure particles or dye-impregnated porous particles The unreacted or unimpregnated dye is separated from the production system, and then the compound to be hydrolyzed is further added dropwise to hydrolyze to obtain the specific composite particles.
When the former, that is, when the reaction is carried out in the same system, composite particles having a three-layer structure are obtained, but the third fixed coating layer has a residual dye that has been digested in a solvent when a colored layer is formed on the core. When the solution to be hydrolyzed to be dripped does not contain a dye even though it is dissolved, the composition has a remarkably small dye content. In this case, the amount is usually about 1/5 or less, preferably 1/10 or less of the dye contained in the colored layer formed directly on the core. This phenomenon is also a phenomenal phenomenon from a general reaction, but its action is not clear at present. Therefore, the manufacturing method of the above-mentioned specific composite particles does not need to take a special reaction form,
It can also be obtained by laminating more than one layer.
The composite particles thus obtained are excellent spherical particles in which the dye hardly elutes even if a small amount of the dye is contained in the third layer.

以上のことから、無機化合物の核と着色層の製造を一連
の操作で行う場合の染料の添加時期は、得られる特定複
合粒子の粒子径を特定の範囲に調製するため及び特定複
合粒子からの染料の溶出を防止するために、核と着色層
の形成に要する全合成時間を1としたときに、0.1〜0.
9、特に好ましくは0.2〜0.8で示される時間内に染料の
添加を開始し、また完了することによって目的の特定複
合粒子とすることが出来る。
From the above, when the addition of the dye in the case of performing the production of the core and the coloring layer of the inorganic compound in a series of operations, in order to adjust the particle size of the resulting specific composite particles in a specific range and from the specific composite particles In order to prevent the elution of the dye, the total synthesis time required for the formation of the core and the colored layer is 0.1 to 0.
The target specific composite particles can be obtained by starting and completing the addition of the dye within the time indicated by 9, particularly preferably 0.2 to 0.8.

前記3層構造以上の多層構造の特定複合粒子を得ると
き、核部の表面にある着色層を被覆した2層構造の粒子
から未反応又は未含浸の染料を分離後例えば該粒子製造
に使用したと同一溶媒で数回洗浄後、該粒子を含む溶媒
中に染料を含まない被加水分解化合物を液滴下し該被加
水分解化合物を加水分解すれば、3層構造目の固定被覆
層は染料をほとんど含まない層となる。
When the specific composite particles having a multi-layer structure of three or more layers are obtained, the unreacted or unimpregnated dye is separated from the particles of the two-layer structure coated with the colored layer on the surface of the core and used for the production of the particles. After washing several times with the same solvent as above, the hydrolyzable compound not containing the dye is dropped into the solvent containing the particles to hydrolyze the hydrolyzable compound, and the fixed coating layer of the third layer structure does not contain the dye. It is a layer that hardly contains it.

前記2層構造又は3層構造を有する特定複合粒子に更に
前記のような処理を行うことにより3層構造以上の多層
の構造を有する複合粒子とすることが出来る。多層構造
の該複合粒子にあっては着色層の着色度合をより鮮明に
表示するため前記固定被覆層を透光性の材料から選ぶの
が好ましい。この意味では固定被覆層は周期律表第III
族又は第IV族の金属或いは該金属と周期律表第I,第II族
又は第V族の金属との複合酸化物であるのが好ましい。
By subjecting the specific composite particles having the two-layer structure or the three-layer structure to the treatment as described above, composite particles having a multi-layer structure of three or more layers can be obtained. In the composite particles having a multi-layered structure, it is preferable to select the fixing coating layer from a light-transmitting material in order to display the coloring degree of the coloring layer more clearly. In this sense, the fixed coating layer is the Periodic Table III.
A group or group IV metal or a complex oxide of the metal and a group I, II or V metal of the periodic table is preferable.

以上説明した水不溶性無機粒子に感作させる生体物質と
しては特に限定的でなく公知のものが使用されるが、好
ましくは抗原、ハプテン及びこれらの免疫によって得ら
れる抗体などの免疫活性物質が用いられる。例えば、免
疫グロブリン、アルブミン、フィブリノーゲン(フィブ
リン及びそれらの分解産物)、α−フェトプロテイン、
C反応性蛋白、β−ミクログロブリン、ミオグロビ
ン、癌胎児性抗原、肝炎ウィルス抗原、ヒト絨毛性ゴナ
ドトロピン、ヒト胎盤性ラクトーゲン、インスリン、ジ
ゴキシン、プロテインA、プロテインG、DNA、RNA等の
蛋白、ホルモン、薬剤など、またそれらの抗体などが挙
げられる。
The biomaterials to be sensitized to the water-insoluble inorganic particles described above are not particularly limited and known ones are used, but immunoactive substances such as antigens, haptens and antibodies obtained by immunization thereof are preferably used. . For example, immunoglobulin, albumin, fibrinogen (fibrin and their degradation products), α-fetoprotein,
C-reactive protein, beta 2 - microglobulin, myoglobin, carcinoembryonic antigen, hepatitis virus antigen, human chorionic gonadotropin, human placental lactogen, insulin, digoxin, protein A, protein G, DNA, proteins such as RNA, hormones , Drugs, and their antibodies.

上記生体物質で本発明の水不溶性無機粒子を感作する方
法は公知の感作方法を採用することができる。例えば、
上記蛋白と水不溶性無機粒子とを水性媒体(例えば、
水、生理食塩水、各種緩衝液など)中で接触させるのが
良く、一般に混合後静置することにより行なわれるが、
接触効率を上げる為撹拌もしくは振とうしても良い。感
作後は、遠心分離及び必要に応じて上記水性媒体で洗浄
して上清中の生体物質を取り除く。
As a method for sensitizing the water-insoluble inorganic particles of the present invention with the above-mentioned biological substance, a known sensitizing method can be adopted. For example,
The above-mentioned protein and water-insoluble inorganic particles in an aqueous medium (for example,
It is preferable to bring them into contact with each other in water, physiological saline, various buffer solutions, etc. Generally, it is carried out by mixing and leaving still,
It may be stirred or shaken to improve the contact efficiency. After the sensitization, the biological material in the supernatant is removed by centrifugation and, if necessary, washing with the above aqueous medium.

本発明において凍結乾燥方法は限定的でなく通常の方法
を行なえば良い。例えば、感作赤血球の凍結乾燥方法に
採用される方法及び条件が用いられる。好ましくは急速
予備凍結し次いで真空凍結乾燥する方法が採用される。
該急速予備凍結は液体窒素、ドライアイス−メタノー
ル、ドライアイス−アセトン、あるいはフルオロカーボ
ン等に、上記生体物質を感作させた凝集反応性粒子を分
散させた浮遊液の入ったバイアル又はアンプルなどの容
器を浸漬することによって達成される。
In the present invention, the freeze-drying method is not limited and any ordinary method may be used. For example, the method and conditions adopted in the freeze-drying method of sensitized red blood cells are used. Preferably, a method of rapid pre-freezing and then vacuum freeze-drying is adopted.
The rapid pre-freezing is performed in liquid nitrogen, dry ice-methanol, dry ice-acetone, or fluorocarbon, etc., and a container such as a vial or ampoule containing a suspension liquid in which agglutination-reactive particles sensitized with the above-mentioned biological material are dispersed. Is achieved by dipping.

該浮遊液の液組成は限定的でなく、従来の凝集反応粒子
製造分野で急速予備凍結に用いられる液組成が採用さ
れ、例えば、種々の緩衝液にグルコース等の糖類、血清
アルブミン、アミノ酸あるいはこれらの混合物を加えた
ものが挙げられる。該浮遊液中の凝集反応性粒子の濃度
は0.05〜50重量%、好ましくは0.1〜10.0重量%になる
様に調整される。
The liquid composition of the suspension is not limited, and the liquid composition used for rapid pre-freezing in the conventional field of producing agglutination reaction particles is adopted. For example, various buffers include saccharides such as glucose, serum albumin, amino acids or the like. And a mixture of the above is added. The concentration of the aggregation-reactive particles in the suspension is adjusted to 0.05 to 50% by weight, preferably 0.1 to 10.0% by weight.

真空凍結乾燥方法は限定的でなく、例えば上記凝集反応
性粒子の浮遊液の入ったバイアルを急速予備凍結したの
ち、あらかじめ−40℃〜−60℃に冷却した凍結乾燥機の
チャンバー内の棚上に置き24〜72時間かけて真空凍結乾
燥する。この時のチャンバー内の圧力は50〜200μHg、
最終乾燥温度は20〜50℃で行なう。次いで真空状態、又
は不活性ガスを充填して封栓保存する。
The vacuum freeze-drying method is not limited, and for example, a vial containing a suspension liquid of the above-mentioned agglutination-reactive particles is rapidly pre-frozen, and then it is cooled to −40 ° C. to −60 ° C. on a shelf in a chamber of a freeze dryer. Place in a vacuum and freeze-dry for 24 to 72 hours. The pressure in the chamber at this time is 50-200 μHg,
The final drying temperature is 20 to 50 ° C. Then, it is vacuumed or filled with an inert gas and stored with a stopper.

このようにして得られる本発明の凝集反応用乾燥試薬を
用いる凝集反応としては何ら制限なく、通常診断に利用
される凝集反応法が適用される。例えば、定性診断の平
板法、半定量法のマイクロタイター法、及び定量法の比
濁法、粒子数計測法等である。好ましくは、操作が簡単
で力価測定が可能であるマイクロタイター法を採用すれ
ば本発明の効果を著しく発揮できる。
There is no limitation on the agglutination reaction using the dry reagent for agglutination reaction of the present invention thus obtained, and the agglutination reaction method usually used for diagnosis is applied. For example, a plate method for qualitative diagnosis, a microtiter method for semi-quantitative method, a turbidimetric method for quantitative method, a particle number measuring method and the like. Preferably, the effect of the present invention can be remarkably exhibited by adopting the microtiter method, which is easy to operate and enables titer measurement.

〔作用及び効果〕[Action and effect]

かくして得られる本発明の凝集反応用乾燥試薬は、用事
の分散性が極めて良好である。
The thus-obtained dry reagent for agglutination reaction of the present invention has extremely good dispersibility in use.

水に対する接触角が80度より大きい水不溶性無機粒子を
用いた凝集反応用乾燥試薬は、使用に際して分散性が非
常に悪く凝集塊が存在し判定の誤りの原因となる。又、
良好な分散性を持つ状態になるまで長い放置時間を要し
凝集反応の特徴である迅速診断上好ましくない。これに
対し、水に対する接触角が80度以下の水不溶性無機粒子
を用いた本発明の凝集反応用乾燥試薬は用事の分散性が
極めて良好で、瞬時に試薬を構成する粒子が分散するの
で迅速な診断が可能なばかりでなく、分散していない凝
集粒子の存在を著しく抑えることができるので判定の誤
りを防ぐことができる。
A dry reagent for agglutination reaction using water-insoluble inorganic particles having a contact angle with water of more than 80 degrees has very poor dispersibility at the time of use and causes agglomerates to cause misjudgment. or,
It takes a long time to stand until it has a good dispersibility, which is not preferable for rapid diagnosis, which is a characteristic of the agglutination reaction. On the other hand, the agglutination reaction dry reagent of the present invention using a water-insoluble inorganic particle having a contact angle to water of 80 degrees or less has extremely good dispersibility in the errand, and the particles constituting the reagent are instantly dispersed so that it is rapid. It is possible not only to perform a simple diagnosis, but also to significantly suppress the presence of aggregated particles that are not dispersed, so that it is possible to prevent erroneous determination.

この理由は必らずしも明確ではないが、水に対する接触
角が80度近傍で乾燥した水不溶性無機粒子の粒子表面の
結合水の量及びコンホメーションが急激に変化する為に
この様な分散性を差異を生じるものと推測される。即
ち、水に対する接触角が80度以下の水不溶性無機粒子を
用いた凝集反応用乾燥試薬は、水に接触させた際に構成
している粒子の表面がより親水的である為に結合水の量
が多くそのコンホメーションも好適に働きすみやかに水
となじむ。この結果、凝集状の粒子群の界面間隙への水
の浸透がすみやかに起こり粒子を一個体ずつ分離して最
終的に完全に1個の粒子群が水に懸濁した分散化が非常
に効率よく行なわれる。
The reason for this is not necessarily clear, but the contact water amount in the vicinity of 80 degrees and the amount of bound water on the particle surface of the water-insoluble inorganic particles dried and the conformation change abruptly. It is speculated that dispersiveness makes a difference. That is, the agglutination reaction dry reagent using a water-insoluble inorganic particles having a contact angle with water of 80 degrees or less, the surface of the particles constituting when contacted with water is more hydrophilic because the surface of the particles is more hydrophilic. A large amount of it works well in its conformation and quickly becomes compatible with water. As a result, the penetration of water into the interfacial space of agglomerated particles occurs promptly, and the particles are separated into individual particles, and finally one particle group is completely suspended in water and dispersion is very efficient. It is often done.

又、本発明においては上記の如く、感作担体として無機
粒子を選択するものであるから赤血球、ポリマー粒子を
使用する場合にくらべて高比重、大粒子径の担体を提供
でき判定が容易かつ迅速になる。更に、表面に抗原性を
有さないので異好性抗体の抗原抗体反応に基づく非特異
的凝集反応を防止できる。更に又、表面特性の制御が容
易で巾広い蛋白を固定できるので診断試薬としての利用
範囲が拡がる。
Further, in the present invention, as described above, since the inorganic particles are selected as the sensitizing carrier, it is possible to provide a carrier having a high specific gravity and a large particle size as compared with the case of using red blood cells and polymer particles, and the determination is easy and quick. become. Furthermore, since the surface has no antigenicity, nonspecific agglutination reaction based on the antigen-antibody reaction of heterophilic antibodies can be prevented. Furthermore, the control of surface characteristics is easy and a wide range of proteins can be immobilized, so that the range of use as a diagnostic reagent is expanded.

本発明は、従来の免疫血清学的検査の凝集反応用乾燥試
薬に比べて著しく用事の分散性が向上した凝集反応用乾
燥試薬を提供するものであり、臨床検査分野へ及ぼす貢
献は極めて大きい。
INDUSTRIAL APPLICABILITY The present invention provides a dry reagent for agglutination reaction in which the dispersibility of the affairs is remarkably improved as compared with the conventional dry reagent for agglutination reaction in immunoserologic tests, and makes a great contribution to the field of clinical examination.

以下、実施例及び比較例を挙げて本発明を更に詳細に説
明するが、本発明はこれらの実施例に限定されるもので
はない。なお、以下の実施例における水不溶性無機粒子
の性状、溶出量及び接触角並びに凝集反応用乾燥試薬の
粒子分散性は以下の方法により測定した。
Hereinafter, the present invention will be described in more detail with reference to Examples and Comparative Examples, but the present invention is not limited to these Examples. The properties of the water-insoluble inorganic particles, the elution amount and the contact angle, and the particle dispersibility of the dry reagent for agglutination reaction in the following examples were measured by the following methods.

(1)平均粒子径() 平均粒子径()は100個以上の粒子の長手方向の直径
を透過型電子顕微鏡で観察して求めた。
(1) Average particle diameter () The average particle diameter () was determined by observing the diameter of 100 or more particles in the longitudinal direction with a transmission electron microscope.

(2)粒度分布〔粒子径の分布値〕(SD) 粒子径の分布値(SD)は各粒子の粒子径の標準偏差を平
均粒子径で除して、100をかけた値である (3)粒子分散値(PD) 粒子分散値(PD)はπ/6(±0.5)の範囲の体積
を有する粒子数を全粒子数で除し、100をかけた値
(%)で表示した。尚、粒子体積の測定と粒子数のカウ
ントはコールターカウンター社製モデルZD−1を用いて
行った。この値は粒子が個々に分散している程度を示す
値である。
(2) Particle size distribution [Distribution value of particle size] (SD) Distribution value of particle size (SD) is a value obtained by dividing the standard deviation of the particle size of each particle by the average particle size and multiplying by 100. (3) Particle dispersion value (PD) The particle dispersion value (PD) is expressed as a value (%) obtained by dividing the number of particles having a volume in the range of π / 6 (± 0.5) 3 by the total number of particles and multiplying by 100. did. The particle volume was measured and the number of particles was counted using Model ZD-1 manufactured by Coulter Counter. This value is a value indicating the degree of individual dispersion of particles.

(4)凝集反応用乾燥試薬粒子分散値(RPD) 乾燥試薬粒子分散値(RPD)は、1mgの凝集反応用乾燥試
薬を生理食塩水5mlに入れ、用手撹拌後1分静置して上
記(3)の粒子分散値と同様にして測定した。
(4) Dry reagent particle dispersion value (RPD) for agglutination reaction As for the dry reagent particle dispersion value (RPD), 1 mg of the dry reagent for agglutination reaction was put in 5 ml of physiological saline, and after manual stirring, left still for 1 minute. It was measured in the same manner as the particle dispersion value of (3).

(5)核部の平均粒子径() 核部を構成する無機化合物粒子について、該無機化合物
粒子を製造した後、前記(1)のの測定と同様にして
測定した。
(5) Average Particle Diameter of Core Part () The inorganic compound particles forming the core part were measured in the same manner as in (1) above after the inorganic compound particles were produced.

(6)無機粒子の溶出量 各水不溶性無機粒子を蒸留水に10重量%となるように分
散させ、この分散液1mlを取り24時間放置後上澄液中の
溶出した無機化合物に起因するイオン原子吸光法により
定量した。
(6) Elution amount of inorganic particles Each water-insoluble inorganic particle was dispersed in distilled water so as to be 10% by weight, and 1 ml of this dispersion was taken and allowed to stand for 24 hours, followed by ions derived from the eluted inorganic compound in the supernatant. It was quantified by the atomic absorption method.

(7)染料の溶出量(SC) メタノールに溶解した染料濃度と該濃度に於ける吸光度
を分光分析し、該染料の吸光係数(ε)を求める。別
に、無機化合物/染料複合粒子をメタノール5mlに5重
量%濃度となるように分散させ、1週間放置後上清4ml
を取り、分光分析し該上清の吸光度(A)を求める。染
料の溶出量(C)を下式より算出した。
(7) Elution amount of dye (SC) The concentration of the dye dissolved in methanol and the absorbance at the concentration are subjected to spectroscopic analysis to obtain the extinction coefficient (ε) of the dye. Separately, the inorganic compound / dye composite particles were dispersed in 5 ml of methanol to a concentration of 5% by weight, and allowed to stand for 1 week.
Is taken and spectroscopically analyzed to determine the absorbance (A) of the supernatant. The elution amount (C) of the dye was calculated by the following formula.

C=A/ε (8)無機化合物/染料複合粒子中の染料含量(DC) 先ず上記(5)と同様な方法で染料の吸光係数(ε)を
求める。別に、メタノールに無機化合物/染料複合粒子
を0.5重量%濃度で分散し、この分散液の4mlをとり、こ
の重量と吸光度(A′)を分光分析する。更に別に、無
機化合物/染料複合粒子の核部を構成する無機化合物
で、該複合粒子と同じ平均粒子径を有する無機化合物粒
子をメタノールに0.5重量%濃度で分散し、この分散液
の吸光度(A″)を分光分析する。
C = A / ε (8) Dye content in inorganic compound / dye composite particles (DC) First, the extinction coefficient (ε) of the dye is determined by the same method as in (5) above. Separately, inorganic compound / dye composite particles are dispersed in methanol at a concentration of 0.5% by weight, 4 ml of this dispersion is taken, and its weight and absorbance (A ') are spectroscopically analyzed. Separately, inorganic compound particles forming the core of the inorganic compound / dye composite particles and having the same average particle diameter as the composite particles are dispersed in methanol at a concentration of 0.5% by weight, and the absorbance (A ″) Is spectroscopically analyzed.

上記測定結果より下記式で該複合粒子中に含まれる染料
の重量(DW)を算出する。
From the above measurement results, the weight (DW) of the dye contained in the composite particles is calculated by the following formula.

DW=(A′−A″)/ε 次いで、前記複合粒子のメタノール分散液4mlの重量か
らアルコール液重量を差引いて、該4ml中の複合粒子重
量(PW)を算出する。
DW = (A′−A ″) / ε Then, the weight of the alcohol liquid is subtracted from the weight of 4 ml of the methanol dispersion liquid of the composite particles to calculate the weight (PW) of the composite particles in the 4 ml.

最後に該複合粒子中の染料含量(DC)を下記式で算出す
る。
Finally, the dye content (DC) in the composite particles is calculated by the following formula.

(9)着色層に含まれる染料の割合(CDC) 無機化合物/染料複合粒子をエポキシ樹脂埋設法で超薄
切片に切出し、該超薄切片を透過型電子顕微鏡で観察す
る。該観察の結果、中心部の濃く見える部分(核部)、
その外側のうすく見える部分(着色層)及び3層以上で
複合粒子が構成されている場合は、3層目以上の外層部
を分析顕微鏡で分析する。該分析で得られる炭素の特定
X線(289eV)の強度より炭素原子数を求め下記式によ
り核部に接する着色層に含まれる染料の割合(CDC)を
算出した。
(9) Proportion of Dye Contained in Colored Layer (CDC) Inorganic compound / dye composite particles are cut into ultrathin sections by an epoxy resin embedding method, and the ultrathin sections are observed with a transmission electron microscope. As a result of the observation, a darkened part (nucleus) of the central part,
When the composite particles are composed of a thinly visible portion (colored layer) on the outside and three or more layers, the outer layer portion of the third layer or more is analyzed with an analytical microscope. The number of carbon atoms was calculated from the intensity of the specific X-ray (289 eV) of carbon obtained by the analysis, and the ratio (CDC) of the dye contained in the colored layer in contact with the core was calculated by the following formula.

(10)接触角 水不溶性無機粒子を100kg/cm2の圧力でプレス加工して
平板状の測定試料を作成したのち、接触角測定装置(ゴ
ニオメーター、エルマ社製)を用い所定の方法により蒸
留水に対する接触角を測定した。
(10) Contact angle Water-insoluble inorganic particles are pressed at a pressure of 100 kg / cm 2 to make a flat measurement sample, and then distilled by a predetermined method using a contact angle measuring device (goniometer, manufactured by Elma Co.). The contact angle with water was measured.

実施例1〜5 (1) 水不溶性無機粒子の合成 撹拌機付きガラス製フラスコ中にメタノール2800cc、ア
ンモニア水(25重量%)616cc、水酸化ナトリウム水溶
液(5モル/)21ccを加え10℃に保った後、テトラエ
チルシリケートのメタノール溶液(22重量%)256mlを2
5.5ml/hrの速度で滴々添加し、シリカ粒子を作成した。
このシリカ粒子を含む反応液中に更にテトラエチルシリ
ケートのメタノール溶液(44重量%)624mlと表1に示
す各種の染料のメタノール溶液(1.25重量%)400mlを
同時に25.5ml/hrの速度で滴々添加し、染料で着色して
着色シリカ粒子を合成した。得られた着色シリカ粒子を
大量のメタノールでデカンテーションによる精製と洗浄
を繰り返した。この染料を含有するシリカ粒子は、いず
れもメタノール中で分散させても、染料の溶出は全くみ
られなかった。
Examples 1 to 5 (1) Synthesis of water-insoluble inorganic particles In a glass flask equipped with a stirrer, 2800 cc of methanol, 616 cc of ammonia water (25% by weight) and 21 cc of aqueous sodium hydroxide solution (5 mol /) were added and kept at 10 ° C. Then, add 256 ml of a solution of tetraethyl silicate in methanol (22 wt%) to 2 ml.
Silica particles were prepared by adding dropwise at a rate of 5.5 ml / hr.
To the reaction solution containing the silica particles, 624 ml of a methanol solution of tetraethyl silicate (44% by weight) and 400 ml of a methanol solution of various dyes shown in Table 1 (1.25% by weight) were simultaneously added dropwise at a rate of 25.5 ml / hr. Then, it was colored with a dye to synthesize colored silica particles. The obtained colored silica particles were repeatedly decanted and purified with a large amount of methanol. No silica elution was observed at all when the silica particles containing this dye were dispersed in methanol.

同様に、染料を含有していない非着色シリカ粒子を合成
した。これは、上記の合成法の中で染料のメタノール溶
液を同時添加しない以外は同じ条件である。
Similarly, non-colored silica particles containing no dye were synthesized. This is the same condition except that the methanol solution of the dye is not added simultaneously in the above synthetic method.

このようにして得られたシリカ粒子を最終的に10重量%
濃度となる様にメタノール中に分散し、その分散液100m
lに表1に示した表面処理剤をそれぞれ0.5重量%濃度に
なる様に添加し、10℃、16時間反応させて表面処理を行
ない表面処理をしたシリカ粒子(着色および非着色)を
得た。これらシリカ粒子の特性を表1に示す。
The silica particles thus obtained are finally added to 10% by weight.
Disperse in methanol to make the concentration 100m
The surface-treating agents shown in Table 1 were added to 1 l so as to each have a concentration of 0.5% by weight and reacted at 10 ° C. for 16 hours to obtain surface-treated silica particles (colored and non-colored). . The characteristics of these silica particles are shown in Table 1.

(2) 熱変性ヒトIgGを感作した水不溶性無機粒子の
合成 ヒトChon F II画分(シグマ社製)を1/150Mリン酸−生
理食塩水緩衝液pH=7.4(以下PBSと略す)に10mg/mlに
なる様溶解し、60℃で10分間加熱することにより熱変性
ヒトIgGを得た。得られた熱変性ヒトIgGをPBSで50倍希
釈した溶液1mlと、前項で得られたシリカ粒子をPBSで1
重量%に希釈した溶液1mlを室温で撹拌しながら、2時
間感作した。
(2) Synthesis of water-insoluble inorganic particles sensitized with heat-denatured human IgG Human Chon F II fraction (manufactured by Sigma) was adjusted to 1/150 M phosphate-saline buffer pH = 7.4 (hereinafter abbreviated as PBS). Heat-denatured human IgG was obtained by dissolving at 10 mg / ml and heating at 60 ° C for 10 minutes. 1 ml of the resulting heat-denatured human IgG diluted 50 times with PBS and the silica particles obtained in the previous section with PBS
1 ml of a solution diluted to weight% was sensitized for 2 hours while stirring at room temperature.

次いで遠心分離して、上清中の熱変性ヒトIgGを除き、
沈渣を少量のショ糖、牛血清アルブミン、グリシンを含
むPBS2mlで再分散した。かくしてシリカ粒子を使用した
凝集反応性粒子の浮遊液を得た。表面処理したシリカ粒
子の場合も同様の操作で行なった。
Then, centrifuge to remove heat-denatured human IgG in the supernatant,
The precipitate was redispersed with 2 ml of PBS containing a small amount of sucrose, bovine serum albumin and glycine. Thus, a suspension of agglutinating reactive particles using silica particles was obtained. The same operation was performed for the surface-treated silica particles.

(3) 凍結乾燥法 (2)で得られた凝集反応性粒子の浮遊液1mlを3ml容バ
イアルに移し、液体窒素でバイアルを急速凍結した後、
あらかじめ−50℃に冷却しておいた凍結乾燥機のチャン
バー内の棚の上に置いた。次いで、100μHgの減圧下で4
0℃の到達温度まで5℃/hrの昇温速度で30時間凍結乾燥
を行なった。
(3) Freeze-drying method Transfer 1 ml of the flocculation reactive particle suspension obtained in (2) to a 3 ml vial and rapidly freeze the vial with liquid nitrogen.
It was placed on a shelf in the chamber of the freeze dryer that had been cooled to -50 ° C in advance. Then, under reduced pressure of 100 μHg, 4
Lyophilization was performed for 30 hours at a temperature rising rate of 5 ° C / hr until the temperature reached 0 ° C.

かくして、リウマチ患者血清中のリウマトイド因子を半
定量するための凝集反応用乾燥試薬が得られた。
Thus, a dry reagent for agglutination reaction for semi-quantifying rheumatoid factor in rheumatoid patient serum was obtained.

(4) 凝集反応用乾燥試薬の分散と抗原、抗体反応 (3)で得られた凝集反応用乾燥試薬の入ったバイアル
に、正常ウサギ血清を少量含有しPBSを2ml加え分散させ
る。
(4) Dispersion of dry reagent for agglutination reaction and antigen / antibody reaction In a vial containing the dry reagent for agglutination reaction obtained in (3), add 2 ml of PBS containing a small amount of normal rabbit serum.

一方、リウマチ患者血清のプール血清をPBSで20倍希釈
したものを原液としてリウマチ患者血清希釈液を調整す
る。抗原抗体反応を行なう為にV型マイクロタイタープ
レートを用意し、リウマチ患者血清希釈液を各ウエルに
25μ加える。次いで上記の正常ウサギ血清を少量含有
したPBSに分散させた凝集反応用乾燥試薬を各ウエルに2
5μ加え、次いで5分間マイクロタイタープレートを
振とうした後室温に静置した。凝集反応用乾燥試薬は分
散5分後にウエルに滴下した。
On the other hand, a pooled serum of rheumatoid patient serum is diluted 20-fold with PBS to prepare a stock solution of a rheumatic patient serum to prepare a diluted solution. Prepare a V-type microtiter plate to carry out antigen-antibody reaction, and add rheumatoid patient serum dilution to each well
Add 25μ. Then, 2 wells of dry reagent for agglutination reaction dispersed in PBS containing a small amount of the above normal rabbit serum was added to each well.
After adding 5 μ, the microtiter plate was shaken for 5 minutes and then left standing at room temperature. The dry reagent for agglutination reaction was added dropwise to the well 5 minutes after dispersion.

次いで抗原・抗体反応に基ずく凝集管底像を肉眼で観察
し、熱変性ヒトIgGを感作した凝集反応用乾燥試薬の性
能を評価した。その結果を表1に示す。
Then, the bottom image of the agglutination tube based on the antigen-antibody reaction was visually observed to evaluate the performance of the dry reagent for agglutination reaction sensitized with heat-denatured human IgG. The results are shown in Table 1.

比較例1,2 表1に示す如く染料及び表面処理剤を変えた以外は実施
例1と同様にして凝集反応用乾燥試薬を作成し性能評価
を行った。その結果を表1に示す。
Comparative Examples 1 and 2 A dry reagent for agglutination reaction was prepared in the same manner as in Example 1 except that the dye and the surface treatment agent were changed as shown in Table 1, and the performance was evaluated. The results are shown in Table 1.

比較例3,4 水不溶性無機粒子のかわりに表1に示すポリスチレンラ
テックスタルクを使用した以外は実施例1と同様に行な
った。その結果を表1に示す。
Comparative Examples 3 and 4 The procedure of Example 1 was repeated except that polystyrene latex talc shown in Table 1 was used instead of the water-insoluble inorganic particles. The results are shown in Table 1.

実施例6,7,8、比較例5,6 ウサギの産生したヒト絨毛性ゴナドトロピン(以下、HC
Gと略す)の抗体をアフィニティークロマトグラフィー
により精製して得た精製HCG抗体を2mg/ml濃度に含有す
るPBSを調整した後、倍数希釈法により希釈してHCG抗体
希釈液を調整した。
Examples 6, 7, 8 and Comparative Examples 5, 6 Human chorionic gonadotropin produced by rabbits (hereinafter referred to as HC
The purified HCG antibody obtained by purifying the antibody (abbreviated as G) by affinity chromatography was adjusted to PBS containing 2 mg / ml concentration, and then diluted by the multiple dilution method to prepare a diluted HCG antibody solution.

次いで、実施例1と同様にして表2に記載した表面処理
剤を使って調製した水不溶性無機粒子の1重量%濃度の
PBSによる希釈液1mlと、上記抗体希釈液1mlを加え、撹
拌しながら室温で1時間感作した。
Then, a water-insoluble inorganic particle prepared by using the surface treatment agent described in Table 2 in the same manner as in Example 1
1 ml of PBS dilution and 1 ml of the above antibody dilution were added and sensitized at room temperature for 1 hour with stirring.

その後、遠心分離して上清中のHCG抗体を除き、沈渣を
少量のショ糖、牛血清アルブミン、グリシンを含むPBS2
mlに再分散した。このHCG抗体を感作した凝集反応性粒
子の浮遊液の凍結乾燥方法は実施例1の方法に準じた。
Then, centrifuge to remove the HCG antibody in the supernatant, and remove the precipitate with a small amount of PBS2 containing sucrose, bovine serum albumin, and glycine.
Redispersed in ml. The method for freeze-drying the suspension of aggregation-reactive particles sensitized with the HCG antibody was in accordance with the method of Example 1.

このようにして得られた凝集反応用乾燥試薬に、正常ウ
サギ血清を少量含有したPBSを2ml加え分散させた。
2 ml of PBS containing a small amount of normal rabbit serum was added to and dispersed in the dry reagent for agglutination reaction thus obtained.

抗原・抗体反応は、HCGを10IU/ml濃度で含むプール妊婦
尿を用いて行なった。まず、プール妊婦尿をPBSで10倍
希釈したものを原液として妊婦尿希釈液を作成する。抗
原抗体反応を行なう為に、マイクロタイタープレートを
用意し妊婦尿希釈液を各ウエルに25μ加える。次い
で、上記凝集反応用乾燥試薬の分散液を各ウエルに25μ
加えた後、5分間マイクロプレートを振とうした後、
室温に静置した。この際凝集反応用乾燥試薬は分散5分
後にウエルに滴下した。次いで、抗原抗体反応に基ずく
凝集管底像を肉眼で観察し、HCG抗体を感作した凝集反
応用乾燥試薬の性能を評価した。その結果を表2に示
す。
The antigen-antibody reaction was performed using pool pregnant woman urine containing HCG at a concentration of 10 IU / ml. First, a pregnant woman urine diluted solution is prepared by using 10 times diluted PBS pregnant woman urine as a stock solution. In order to carry out the antigen-antibody reaction, prepare a microtiter plate and add 25 μl of pregnant woman urine dilution to each well. Then, 25 μl of the dispersion of the dry reagent for the agglutination reaction was added to each well.
After adding, shaking the microplate for 5 minutes,
It was left at room temperature. At this time, the agglutination reaction dry reagent was added dropwise to the well 5 minutes after dispersion. Then, the bottom image of the agglutination tube based on the antigen-antibody reaction was visually observed to evaluate the performance of the HCG antibody-sensitized dry reagent for agglutination reaction. The results are shown in Table 2.

実施例9〜13、比較例7〜11 表1の実施例2の水不溶性無機粒子に、実施例1の方法
に準じて熱変性ヒトIgGを感作した凝集反応性粒子を調
製した。
Examples 9 to 13 and Comparative Examples 7 to 11 The water-insoluble inorganic particles of Example 2 in Table 1 were sensitized with heat-denatured human IgG in accordance with the method of Example 1 to prepare aggregation-reactive particles.

この凝集反応性粒子を表3に示した組成の添加剤を含む
浮遊液に浮遊させた以外は実施例1の方法と同様にして
凝集反応用乾燥試薬を得た。
A dry reagent for agglutination reaction was obtained in the same manner as in Example 1 except that the agglutination-reactive particles were suspended in a suspension containing the additive having the composition shown in Table 3.

かくして得られた熱変性ヒトIgGを感作した凝集反応用
乾燥試薬の抗原抗体反応の性能を表3に示した。
The performance of the antigen-antibody reaction of the dried reagent for agglutination reaction sensitized with the heat-denatured human IgG thus obtained is shown in Table 3.

比較のため、ポリスチレンを同様に処理して得られた凝
集反応用試薬の性能もあわせて表3に示した。
For comparison, the performance of the agglutination reaction reagent obtained by similarly treating polystyrene is also shown in Table 3.

実施例14、比較例12 表1の実施例3の水不溶性無機粒子に実施例1の方法に
準じて熱変性ヒトIgGを感作した凝集反応性粒子を調製
後、凍結乾燥して凝集反応用乾燥試薬を得た。
Example 14, Comparative Example 12 Water-insoluble inorganic particles of Example 3 in Table 1 were sensitized with heat-denatured human IgG according to the method of Example 1 to prepare aggregation-reactive particles, which were then lyophilized to be used for aggregation reaction. A dry reagent was obtained.

この熱変性ヒトIgGを感作した凝集反応用乾燥試薬の抗
原抗体反応の性能を実施例1の方法に準じ、以下の方法
で調べた。即ち、凝集反応用乾燥試薬の入ったバイアル
に正常ウサギ血清を少量含有したPBSを2ml加え分散さ
せ、この分散液をあらかじめリウマチ患者血清希釈液の
入れてある各ウエルに加えるまでの放置時間を変化させ
試薬性能に及ぼす影響を調べた。
The performance of the antigen-antibody reaction of the dry reagent for agglutination reaction sensitized with this heat-denatured human IgG was examined by the following method according to the method of Example 1. That is, 2 ml of PBS containing a small amount of normal rabbit serum was added to a vial containing a dry reagent for agglutination reaction to disperse, and the standing time before adding this dispersion to each well containing the diluted serum of rheumatism patients was changed. The influence on the reagent performance was investigated.

その結果を表4に示す。比較のために表1の比較例2の
水不溶性無機粒子を用いて製造した凝集反応用乾燥試薬
も同様にして調べ、その結果をあわせて表4に示す。
The results are shown in Table 4. For comparison, a dry reagent for agglutination reaction produced using the water-insoluble inorganic particles of Comparative Example 2 in Table 1 was also examined in the same manner, and the results are also shown in Table 4.

実施例15 表1の実施例2の水不溶性無機粒子を用いてB型肝炎ウ
イルス抗原(以下、HBsと略す)を検出する平板法用の
凝集反応用乾燥試薬を以下のように調製した。
Example 15 A dry reagent for agglutination reaction for a plate method for detecting hepatitis B virus antigen (hereinafter abbreviated as HBs) using the water-insoluble inorganic particles of Example 2 in Table 1 was prepared as follows.

ヤギの産生したHBsの抗体をアフィニティークロマトグ
ラフィーにより精製して得た精製HBs抗体を2mg/ml濃度
に含有するPBSを調製したのち、倍数希釈法により希釈
してHBs抗体希釈液を作成した。次いで、実施例1に準
じて感作、凍結乾燥を行ない凝集反応用乾燥試薬を得た
のちPBS4mlに分散させた。
A HBs antibody diluted solution was prepared by preparing PBS containing purified HBs antibody at a concentration of 2 mg / ml obtained by purifying the goat-produced HBs antibody by affinity chromatography and then diluting it by the multiple dilution method. Then, sensitization and lyophilization were carried out according to Example 1 to obtain a dry reagent for agglutination reaction, which was then dispersed in 4 ml of PBS.

抗原抗体反応は種々の濃度のHBsを含むヒト血清をPBSに
20倍に希釈後、この希釈液25μと上記凝集反応用乾燥
試薬の分散液25μを、ガラス平板上で撹拌混合し3分
後の凝集像の強さを測定した。凝集反応用乾燥試薬は分
散5分後にガラス平板上に滴下した。ガラス平板法によ
る凝集結果を表5に示した。
The antigen-antibody reaction was performed by using human serum containing various concentrations of HBs in PBS.
After 20-fold dilution, 25 μ of this diluted solution and 25 μ of a dispersion of the above-mentioned dried reagent for agglutination reaction were mixed by stirring on a glass plate, and the strength of the agglutination image was measured after 3 minutes. The dry reagent for agglutination reaction was dropped on a glass plate 5 minutes after the dispersion. Table 5 shows the results of aggregation by the glass plate method.

比較例として、表2の比較例6の無機粒子を用いて作成
した凝集反応用乾燥試薬を同様の方法で評価した結果、
分散性が不良で非特異凝集を生じた。
As a comparative example, a dry reagent for agglutination reaction prepared using the inorganic particles of Comparative Example 6 in Table 2 was evaluated by the same method,
Poor dispersibility resulted in non-specific aggregation.

実施例16,17,18 撹拌機付きガラス製フラスコにイソプロピルアルコール
(IPA)2800ccと水28ccを加え10℃に保ったのち、表6
に示す各被加水分解化合物の30重量%IPA溶液1020mlを2
2.5ml/時の速度で滴々添加し各無機化合物粒子を得た。
これらの粒子を実施例1と同様に洗浄、精製後γ−グリ
シドプロピルトリメトキシシランを用いて表面処理し
た。これらの水不溶性無機粒子に実施例1と同様にして
熱変性ヒトIgGを感作、凍結乾燥して凝集反応用乾燥試
薬を得、マイクロタイター法によって性能を評価した。
その結果をあわせて表6に示す。
Examples 16, 17, and 18 To a glass flask equipped with a stirrer, 2800 cc of isopropyl alcohol (IPA) and 28 cc of water were added and kept at 10 ° C., and then Table 6
1020 ml of a 30 wt% IPA solution of each compound to be hydrolyzed shown in 2
The inorganic compound particles were obtained by dropwise addition at a rate of 2.5 ml / hour.
These particles were washed and purified in the same manner as in Example 1 and then surface-treated with γ-glycidpropyltrimethoxysilane. These water-insoluble inorganic particles were sensitized with heat-denatured human IgG in the same manner as in Example 1 and lyophilized to obtain a dry reagent for agglutination reaction, and the performance was evaluated by the microtiter method.
The results are also shown in Table 6.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】水に対する接触角が80度以下である水不溶
性無機化合物であって、平均粒子径が0.1〜10.0μm
で、粒子分散値が80%以上の粒子の表面に生体物質を感
作した凝集反応性粒子の浮遊液を凍結乾燥して得た凝縮
反応用乾燥試薬
1. A water-insoluble inorganic compound having a contact angle with water of 80 degrees or less and having an average particle diameter of 0.1 to 10.0 μm.
A dry reagent for condensation reaction obtained by freeze-drying a suspension of agglutinating reactive particles in which biological material is sensitized on the surface of particles having a particle dispersion value of 80% or more.
JP62235012A 1987-09-21 1987-09-21 Drying reagent for agglutination reaction Expired - Fee Related JPH0740030B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62235012A JPH0740030B2 (en) 1987-09-21 1987-09-21 Drying reagent for agglutination reaction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62235012A JPH0740030B2 (en) 1987-09-21 1987-09-21 Drying reagent for agglutination reaction

Publications (2)

Publication Number Publication Date
JPS6478161A JPS6478161A (en) 1989-03-23
JPH0740030B2 true JPH0740030B2 (en) 1995-05-01

Family

ID=16979762

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62235012A Expired - Fee Related JPH0740030B2 (en) 1987-09-21 1987-09-21 Drying reagent for agglutination reaction

Country Status (1)

Country Link
JP (1) JPH0740030B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016117054A1 (en) * 2015-01-21 2016-07-28 コニカミノルタ株式会社 Phosphor aggregate nanoparticle used in fluorescence observation

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5174746A (en) * 1990-05-11 1992-12-29 Sumitomo Metal Mining Company Limited Method of operation of flash smelting furnace

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH582884A5 (en) * 1973-12-10 1976-12-15 Hoffmann La Roche
JPS6089754A (en) * 1983-10-24 1985-05-20 Eiken Kagaku Kk Carrier for adsorption of immunoactive material
EP0156537A3 (en) * 1984-03-02 1987-05-13 Board Of Regents University Of Texas System Biological magnetic fluids
JPS63171363A (en) * 1987-01-09 1988-07-15 Terumo Corp Particle for immunoagglutination reaction

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016117054A1 (en) * 2015-01-21 2016-07-28 コニカミノルタ株式会社 Phosphor aggregate nanoparticle used in fluorescence observation

Also Published As

Publication number Publication date
JPS6478161A (en) 1989-03-23

Similar Documents

Publication Publication Date Title
RU2025732C1 (en) Method of analyte immunoassay in aqueous sample
JPH0611870B2 (en) Inorganic compound / dye composite particles
CN1092866A (en) A kind of based on light scattering and there is not the immune analysis method of particle self aggregation situation
JPH0731206B2 (en) Test apparatus, kit and method for ligand measurement using immobilized biotinylated receptor
WO1987003690A1 (en) Particle-bound binding component immunoassay
JPS63229367A (en) Immuno-reactive reagent, manufacture thereof and application thereof for measuring immuno-reactive specy
JP2001502795A (en) Method and apparatus useful for detecting blood group antigens and antibodies
WO1992021974A1 (en) Stable alkaline phosphatase compositions with color enhancement and their use in assays
CN102435752A (en) Human myoglobin (Myoglobin) quantitative assay kit and detection method thereof
JP4086266B2 (en) Immunoassay method
JP3413415B2 (en) Immunoassay reagent and immunoassay using the same
EP0609265B1 (en) Unit-of-use reagent composition for specific binding assays
JPH0740030B2 (en) Drying reagent for agglutination reaction
EP0280557B1 (en) Test kit, extraction device and method for the determination of streptococcus a antigen
JPH073426B2 (en) Carrier of diagnostic agglutination reagent
JPH0688822A (en) Method for measuring material to be analyzed in aqueous sample, measuring reagent and measuring reagent kit
JP2745705B2 (en) Antigen / antibody assay
JP6683907B2 (en) Immune aggregation particles and method for producing the same
US3955923A (en) Serologic reaction method
WO1993007466A1 (en) Unit-of-use reagent compositions for specific binding assays
JPH0468588B2 (en)
JPH09304386A (en) Method for producing immunodiagnostic agent and obtained immunodiagnostic agent
JP3845118B2 (en) Method for binding a ligand in an acidic solution and an anionic surfactant to a solid phase
JP3657015B2 (en) Reagent kit for immune reaction measurement
JPS62115366A (en) Immunodiagnostic reagent

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees